Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05651581 · ClinicalTrials.gov registry record · NA

Efficacy and Acceptability of a Monkeypox Curriculum for Disproportionately Impacted Communities

A NA study, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
200
Enrollment target

NCT05651581 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 200 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05651581, a NA study, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
200 participants
Enrollment target

Study Summary

The study team will create an online module via the REDCap platform. The module will include around 5 videos and several infographics covering the topics of symptoms, transmission, prevention, vaccination, and treatment of the monkeypox virus. Surveys assessing the primary and secondary study endpoints will be given to participants before and after the module. The purpose of the study is to assess the efficacy and acceptability of an educational presentation on monkeypox in a cohort of individuals recruited from Rainbow Health and to secondarily assess participant risk perception, intention to vaccinate, and confidence in public health initiatives.

Interventions

  • OTHER Online module

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2023-05-24
Est. Completion 2023-08-24
Phase NA

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT05651581

The ClinicalTrials.gov registry entry for NCT05651581 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Online module is the first listed.

NCT05651581 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05651581 about?

NCT05651581 is a clinical study titled "Efficacy and Acceptability of a Monkeypox Curriculum for Disproportionately Impacted Communities". The study team will create an online module via the REDCap platform. The module will include around 5 videos and several infographics covering the topics of symptoms, transmission, prevention, vaccination, and treatment of the monkeypox virus. Surveys assessing the primary and secondary study endpoi...

What is the current status of trial NCT05651581?

This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2023-05-24. Estimated completion is 2023-08-24.

What interventions are being tested in trial NCT05651581?

The interventions under investigation include: Online module (OTHER).

Who is sponsoring clinical trial NCT05651581?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.